Stem cell chief Dr. Maria Millan sheds light on CIRM's future and potential 2020 bond

Favicon The San Francisco Business Times

Millan says CIRM is on track to meet its three-year goal of funding new clinical trials and explains why the institute appeals to the same people passionate about start-ups.

Read the full article here: The San Francisco Business Times


The post: «Stem cell chief Dr. Maria Millan sheds light on CIRM's future and potential 2020 bond» has been published on the website The San Francisco Business Times where, everyday, you can find the latest news about San Francisco's area.



Get more articles about this topic

Leave a comment